Not logged in Share Save
Share Save
Share Save
Share Save
Real-world comparison between neoadjuvant FLOT therapy and DCF therapy for resectable esophagogastric junction adenocarcinoma Shiraishi, Kazuhiro; Yamamoto, Shun; Hirose, Toshiharu; Imazeki, Hiroshi; Yokoyama, Kazuki; Honma, Yoshitaka; Hashimoto, Taiki; Kashihara, Tairo; Kurita, Daisuke; Ishiyama, Koshiro; Oguma, Junya; Igaki, Hiroshi; Daiko, Hiroyuki; Seto, Yasuyuki; Kato, Ken Share Save
Share Save
The safety and short-term efficacy of nivolumab plus ipilimumab for advanced esophageal squamous cell carcinoma Shiraishi, Kazuhiro; Yamamoto, Shun; Yoshinami, Yuri; Ogura, Nozomu; Itoyama, Mai; Imazeki, Hiroshi; Yokoyama, Kazuki; Honma, Yoshitaka; Kashihara, Tairo; Kurita, Daisuke; Ishiyama, Koshiro; Oguma, Junya; Igaki, Hiroshi; Daiko, Hiroyuki; Seto, Yasuyuki; Kato, Ken Share Save
Safety and short-term efficacy of neoadjuvant FLOT therapy in cisplatin-unfit patients with resectable esophageal squamous cell carcinoma Yoshinami, Yuri; Yamamoto, Shun; Shiraishi, Kazuhiro; Imazeki, Hiroshi; Yokoyama, Kazuki; Honma, Yoshitaka; Kurita, Daisuke; Ishiyama, Koshiro; Oguma, Junya; Hashimoto, Taiki; Kashihara, Tairo; Daiko, Hiroyuki; Kato, Ken Share Save
Quality indicator survey of clinical practice guidelines for esophagogastric junction cancer 2023 Matsuda, Satoru; Wijnhoven, Bas; Lordick, Florian; Bhandari, Pradeep; Liu, Fenglin; Kato, Ken; Gotoda, Takuji; Ferri, Lorenzo; Takeuchi, Hiroya; Kakeji, Yoshihiro; Yang, Han-Kwang; Kitagawa, Yuko Share Save
Share Save
Share Save
Share Save
Postoperative Recurrence Pattern of Clinical Stage I Esophageal Cancer After Esophagectomy with Two- or Three-Field Lymph Node Dissection: Supplementary Analysis from JCOG0502 Bamba, Takeo; Kato, Ken; Daiko, Hiroyuki; Ito, Yoshinori; Kajiwara, Takeshi; Fujita, Takeo; Miyata, Hiroshi; Machida, Ryunosuke; Sasaki, Keita; Takeuchi, Hiroya; Kitagawa, Yuko Share Save
First-Line Tislelizumab Plus Chemotherapy for Esophageal Squamous Cell Carcinoma with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-306 Xu, Jianming; Kato, Ken; Hubner, Richard; Park, Sook Ryun; Kojima, Takashi; Ishihara, Ryu; Wyrwicz, Lucjan; Van Cutsem, Eric; Jimenez-Fonseca, Paula; Wu, Hongqian; Wang, Lei; Yan, Sebastian; Shi, Jingwen; Kadva, Alysha; Yoon, Harry H. Share Save
First-Line Tislelizumab Plus Chemotherapy for Advanced Gastric Cancer with Programmed Death-Ligand 1 Expression ≥ 1%: A Retrospective Analysis of RATIONALE-305 Moehler, Markus; Oh, Do-Youn; Kato, Ken; Arkenau, Tobias; Tabernero, Josep; Lee, Keun-Wook; Rha, Sun Young; Hirano, Hidekazu; Spigel, David; Yamaguchi, Kensei; Wyrwicz, Lucjan; Disel, Umut; Pazo-Cid, Roberto A.; Fornaro, Lorenzo; Xu, Yaling; Sheng, Tao; Yang, Silu; Kadva, Alysha; Cruz-Correa, Marcia; Xu, Rui-Hua Share Save
The Relationship Between the Percent Coefficient of Variation of Sensor Glucose Levels and the Risk of Severe Hypoglycemia or Non-Severe Hypoglycemia in Patients With Type 1 Diabetes: Post Hoc Analysis of the ISCHIA Study Murata, Takashi; Matsuhisa, Munehide; Kuroda, Akio; Toyoda, Masao; Hirota, Yushi; Ogura, Masahito; Suzuki, Shota; Kato, Ken; Tone, Atsuhito; Matoba, Yuka; Meguro, Shu; Miura, Junnosuke; Nishimura, Kunihiro; Shimada, Akira; Hosoda, Kiminori; Sakane, Naoki; ISCHIA Study Grp Share Save
Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody (PADDLE) Hirano, Hidekazu; Takahashi, Naoki; Amanuma, Yusuke; Suzuki, Nobumi; Takahari, Daisuke; Kawakami, Takeshi; Kudo-Saito, Chie; Nagashima, Kengo; Boku, Narikazu; Kato, Ken; Shoji, Hirokazu Share Save
Share Save
Immune checkpoint inhibitors in advanced gastroesophageal adenocarcinoma: a series of patient-level meta-analyses in different programmed death-ligand 1 subgroups Leone, A. G.; Mai, A. S.; Fong, K. Y.; Yap, D. W. T.; Kato, K.; Smyth, E.; Moehler, M.; Seong, J. T. C.; Sundar, R.; Zhao, J. J.; Pietrantonio, F. Share Save
Phase II Trial of Adjuvant S-1 Following Neoadjuvant Chemotherapy and Surgery in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: The PIECE Trial Nomura, Motoo; Yamaguchi, Toshifumi; Chin, Keisho; Hato, Shinji; Kato, Ken; Baba, Eishi; Matsubara, Hisahiro; Mukaida, Hidenori; Yoshii, Takako; Tsuda, Masahiro; Tsubosa, Yasuhiro; Kitagawa, Yuko; Oze, Isao; Ishikawa, Hideki; Muto, Manabu Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
